Hans Heijst

625 total citations
10 papers, 431 citations indexed

About

Hans Heijst is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Hans Heijst has authored 10 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 4 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Hans Heijst's work include Alzheimer's disease research and treatments (3 papers), Dementia and Cognitive Impairment Research (3 papers) and Prion Diseases and Protein Misfolding (2 papers). Hans Heijst is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Dementia and Cognitive Impairment Research (3 papers) and Prion Diseases and Protein Misfolding (2 papers). Hans Heijst collaborates with scholars based in Netherlands, United States and Austria. Hans Heijst's co-authors include Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Inge M.W. Verberk, Rosalinde E.R. Slot, Niels D. Prins, Sander C.J. Verfaillie, Bart N.M. van Berckel, Yolande A.L. Pijnenburg and John C. Janssen and has published in prestigious journals such as Brain, Annals of Neurology and Scientific Reports.

In The Last Decade

Hans Heijst

9 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans Heijst Netherlands	8	279	226	93	90	73	10	431
Natalia Ermann Germany	5	187 0.7×	134 0.6×	79 0.8×	78 0.9×	57 0.8×	6	299
Jasmin Rahimi Austria	7	198 0.7×	127 0.6×	119 1.3×	130 1.4×	121 1.7×	7	390
Flora Berisha United States	5	247 0.9×	114 0.5×	130 1.4×	149 1.7×	84 1.2×	9	411
Carolin Heller United Kingdom	9	190 0.7×	86 0.4×	117 1.3×	156 1.7×	86 1.2×	13	422
Eftychia Bellou United Kingdom	8	201 0.7×	94 0.4×	139 1.5×	58 0.6×	119 1.6×	15	463
Giordano Cecchetti Italy	10	149 0.5×	125 0.6×	62 0.7×	88 1.0×	38 0.5×	35	388
Yannick Tholance France	15	325 1.2×	238 1.1×	187 2.0×	281 3.1×	87 1.2×	36	760
Valentina Albertini Italy	14	224 0.8×	78 0.3×	186 2.0×	152 1.7×	85 1.2×	22	528
Daisuke Yanase Japan	12	226 0.8×	211 0.9×	114 1.2×	53 0.6×	78 1.1×	21	516
Tobi Van den Bossche Belgium	9	172 0.6×	125 0.6×	109 1.2×	93 1.0×	73 1.0×	12	426

Countries citing papers authored by Hans Heijst

Since Specialization

Citations

This map shows the geographic impact of Hans Heijst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Heijst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Heijst more than expected).

Fields of papers citing papers by Hans Heijst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Heijst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Heijst. The network helps show where Hans Heijst may publish in the future.

Co-authorship network of co-authors of Hans Heijst

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Heijst. A scholar is included among the top collaborators of Hans Heijst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Heijst. Hans Heijst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Teunissen, Charlotte E., Christa Walgaard, Hans Heijst, et al.. (2024). Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome. EBioMedicine. 102. 105072–105072. 17 indexed citations

Heijst, Hans, Eline A.J. Willemse, Mardien L. Oudega, et al.. (2023). Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases. Brain Communications. 5(2). fcad120–fcad120. 9 indexed citations

Zeggeren, Ingeborg E. van, Liora ter Horst, Hans Heijst, et al.. (2022). Neurofilament light chain in central nervous system infections: a prospective study of diagnostic accuracy. Scientific Reports. 12(1). 14140–14140. 8 indexed citations

Heijst, Hans, Eline A.J. Willemse, Mardien L. Oudega, et al.. (2022). Neurofilament light chain cannot be measured in urine to distinguish frontotemporal dementia with primary psychiatric diseases. Alzheimer s & Dementia. 18(S6).

Thijssen, Elisabeth H., Inge M.W. Verberk, Jeroen Vanbrabant, et al.. (2021). Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease. Scientific Reports. 11(1). 9736–9736. 52 indexed citations

Beerepoot, Shanice, Hans Heijst, Birthe Roos, et al.. (2021). Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy. Brain. 145(1). 105–118. 25 indexed citations

Verberk, Inge M.W., Rosalinde E.R. Slot, Sander C.J. Verfaillie, et al.. (2018). Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes. Annals of Neurology. 84(5). 648–658. 219 indexed citations

Thijssen, Elisabeth H., Inge M.W. Verberk, Hugo Vanderstichele, et al.. (2018). O3‐09‐06: A PROTOTYPE SIMOA ASSAY QUANTIFYING PLASMA AMYLOID BETA 1‐42 AND 1‐40 ISOFORMS CAN DIFFERENTIATE PARTICIPANTS WITH AD FROM HEALTHY CONTROL SUBJECTS. Alzheimer s & Dementia. 14(7S_Part_19). 4 indexed citations

Pijnenburg, Yolande A.L., John C. Janssen, Niki S.M. Schoonenboom, et al.. (2007). CSF Neurofilaments in Frontotemporal Dementia Compared with Early Onset Alzheimer’s Disease and Controls. Dementia and Geriatric Cognitive Disorders. 23(4). 225–230. 69 indexed citations

10.

Familian, Atoosa, Alexandre E. Voskuyl, G J van Mierlo, et al.. (2005). Infliximab treatment reduces complement activation in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 64(7). 1003–1008. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact